Amy Goffena, NP
Adult Health · Billings, MTNPI 1679246425
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $490 and has fallen 91.7% since, to $41 in 2025. That places this record below the midpoint for adult health clinicians in MT, where the typical reported total is $768.
Across 14 payments — averaging $54.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$145
- AbbVie$140
- Sanofi-aventis U.S. LLC$136
- Medtronic$86
- Lilly USA, LLC$63
- Insulet Corporation$58
- plus $141 from 5 others
What the payments were for
- Food & beverage$768100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1 | $145 |
| AbbVie | 1 | $140 |
| Sanofi-aventis U.S. LLC | 1 | $136 |
| Medtronic | 1 | $86 |
| Lilly USA, LLC | 3 | $63 |
| Insulet Corporation | 1 | $58 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Boehringer Ingelheim | 1 | $31 |
| Dexcom, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Novartis | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre Pro$145
- Elahere$140
- TZIELD$136
How this compares
$768 in reported general payments places this provider in the 50th percentile of 27 adult health providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $61,152 |
| JardianceEmpagliflozin | 48 | $47,269 |
| MounjaroTirzepatide | 38 | $39,980 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $24,394 |
| JanuviaSitagliptin Phosphate | 23 | $20,352 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 15 | $17,988 |
| TrulicityDulaglutide | 12 | $14,963 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $7,300 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $7,259 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,433 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $5,575 |
| Novolog FlexpenInsulin Aspart | 30 | $5,365 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 38 | $3,671 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 22 | $2,280 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 16 | $974 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $23 | $61,15244 claims |
| Lilly USA, LLCMounjaro, Trulicity | $63 | $54,94350 claims |
| Boehringer IngelheimJardiance | $31 | $47,26948 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 27 adult health providers in Montana.
Other adult health in Billings
- Tauna JefferyBillings$4K
- Brittany SilversBillings$4K
- Joslyn ThompsonBillings$3K
- Karista WalshBillings$3K
- Janice OstermillerBillings$3K
- Gregory HubbsBillings$2K
- Kimberly AckermanBillings$2K
- Robin GarlandBillings$1K
- Diane TruchotBillings$592
- Anna WeberBillings$325
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.